Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
22
VKTX Quote, Financials, Valuation and Earnings
Last price:
$42.27
Seasonality move
:
40.87%
Day range:
$41.98 - $45.00
52-week range:
$17.23 - $99.41
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
5.17x
Volume:
8.7M
Avg. volume:
4.3M
1-year change:
139.78%
Market cap:
$4.7B
Revenue:
--
EPS (TTM):
-$0.93
VKTX Analysts' Consensus Rating
The 9 analysts providing 12-month price projections for Viking Therapeutics shares anticipate an average target of $110.00, ranging from a low estimate of $74.00 to a high estimate of $164.00. This average target implies a growth of 160.36% compared to the current stock price of $42.25.
Consensus Price Target
$110.00
Highest Price Target
$164.00
Lowest Price Target
$74.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 8 | 9 | 9 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
VKTX Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
